Who owns COMPASS Pathways plc (CMPS)? Elite investor 13F holders
3 tracked elite investors reported holding COMPASS Pathways plc as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | COMPASS PATHWAYS PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 20261229.00 USD | 1431889.000000 | Shares | add | Original filing |
| D.E. Shaw | COMPASS PATHWAYS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3408367.00 USD | 240874.000000 | Shares | add | Original filing |
| Saba Capital | COMPASS PATHWAYS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Ancora Advisors / Ancora Holdings | COMPASS PATHWAYS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 43440.00 USD | 3070.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.